Source MS Trust: NICE has announced that it is pausing the publication of final guidance for ocrelizumab for primary progressive multiple sclerosis. The final decision was due to be published on the NICE website on 31 October and would have rejected ocrelizumab as an NHS treatment for primary progressive MS on the grounds of cost-effectiveness. The MS Trust now understands that… Read more »
Posts By: Karen Jones
Centre Christmas Lunch
Date – Wednesday 12th December Time – 12 for 12.30 Venue – Park Place Brasserie, Milton Park Price – 3 courses £18, 2 courses £16 (including tip) Starters Leek and Potato Soup (V) (GF) Salmon Gravadlax with a Beetroot and Horseradish Salad and Caper Dressing Chicken Liver Pate with Festive Chutney all served with… Read more »
October 100 club winners
October 100 club winners: 1st Sue Doran 2nd Babs Copley 3rd Angie Duncan Join our 100 club for a share of the 100 prize fund every month, speak to Sue or Reception for details, just £5 a month.
Milton Park Monthly Updates
30th October 2018 Issue 002 This newsletter brings you the latest and greatest stories from around the park. October has been a busy month, with November set to be even busier with the opening of Courtyard by Marriott on 12th November. Please contact Jordan Rowefor more information. Carry on reading to find our more! Published… Read more »
Date for your diaries
Date for your diaries: WEDS 12th DECEMBER, MS Centre Christmas Lunch at Park Place Brasserie, Milton Park, 12 for 12.30. Further details will follow soon.
Novartis bets priority review voucher on its next big multiple sclerosis drug — eyes US, EU approvals in ’19
Source Endpoints News: One of Novartis’ top late-stage candidates for multiple sclerosis is now under review on both sides of the Atlantic. Having stoked enthusiasm for siponimod through a solid Phase III data package, the Swiss drugmaker traded in a priority review voucher at the FDA for an expedited action date around March of next year…. Read more »
Former watchdog chief labels disabled benefits process a ‘hostile environment’
Source The Guardian: Andrew McDonald, who chaired Independent Parliamentary Standards Authority, says the system is ‘Kafka-esque’ A former top civil servant has criticised the disability benefits assessment system as a “hostile environment” after being told he was ineligible for support despite having Parkinson’s and terminal prostate cancer. Andrew McDonald, 56, who ran the parliamentary body overseeing… Read more »
Medical Cannabis To Be Available On Prescription ‘Within Weeks’
Source Huffington Post: Medical cannabis will be available on prescription in the UK within a month, according to The Telegraph. The Home Office is expected to announce the “rescheduling” of cannabis-derived medicines in Parliament within a fortnight, lifting restrictions which mean that until now it has only been allowed in the most exceptional circumstances within a matter… Read more »
Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
Source Neurology Advisor: Increased levels of physical activity may lead to decreased vascular risk profiles in patients with multiple sclerosis, according to a literature review published in Multiple Sclerosis and Related Disorders. Researchers in this review searched for published articles in 5 major databases for studies involving physical activity, sedentary lifestyles, or exercise training and the impact these… Read more »
Benefit errors trigger £5,000 refunds
Source BBC: Assessors wrongly calculated the income of thousands of people during the process that resulted in people moving from incapacity benefit and severe disability allowance onto ESA. Tens of thousands of people on sickness benefits will receive backdated payments averaging £5,000 following government errors. The Department for Work and Pensions (DWP) has revealed it is… Read more »
